Patient Guide: Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 126 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02598661
Status: ACTIVE_NOT_RECRUITING
Condition: Myelodysplastic Syndromes
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 126 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Tucson, Arizona
  • Bakersfield, California
  • • And 123 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily